Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes With Novel Approaches to Targeted Therapy

Learn about novel approaches to targeted therapy in the treatment of patients with relapsed/refractory DLBCL with this on-demand webcast and downloadable slides from a live Grand Rounds series.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner
ProCE Banner

Jointly provided by USF Health and Rockpointe.

Supporters

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc